|
|
Volumn 11, Issue 12, 2016, Pages e147-e149
|
|
Response to Pembrolizumab in a Patient with Relapsing Thymoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GLUCOCORTICOID;
IMMUNOGLOBULIN;
INFLIXIMAB;
PACLITAXEL;
PEMBROLIZUMAB;
PROGRAMMED DEATH 1 LIGAND 1;
ANTINEOPLASTIC AGENT;
IMMUNOLOGICAL ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
ADJUVANT RADIOTHERAPY;
ADULT;
ARTICLE;
CANCER STAGING;
CANCER SURGERY;
CASE REPORT;
CHEMORADIOTHERAPY;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG SAFETY;
DRUG WITHDRAWAL;
EPITHELIUM CELL;
HOSPITALIZATION;
HUMAN;
HUMAN TISSUE;
INDUCTION CHEMOTHERAPY;
MALE;
MIDDLE AGED;
MULTIPLE CYCLE TREATMENT;
NEXT GENERATION SEQUENCING;
PERICARDIUM;
PLASMAPHERESIS;
PROTEIN EXPRESSION;
SKIN TOXICITY;
THORACOTOMY;
THYMOMA;
TREATMENT RESPONSE;
TREATMENT WITHDRAWAL;
TUMOR RECURRENCE;
TUMOR REGRESSION;
PATHOLOGY;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
RADIOTHERAPY, ADJUVANT;
THYMOMA;
THYMUS NEOPLASMS;
|
|
EID: 85010777973
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1016/j.jtho.2016.07.018 Document Type: Article |
|
Times cited : (33)
|
|
References (5)
|
